Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Resin Regeneration and Storage – V 2.0

Posted on By


Biosimilars: SOP for Resin Regeneration and Storage – V 2.0


Standard Operating Procedure for Resin Regeneration and Storage in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/169/2025
Supersedes SOP/BS/169/2022
Page No. Page 1 of 9
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for the regeneration and storage of chromatography resins used in biosimilar manufacturing to maintain resin performance, prevent microbial growth, and ensure compliance with GMP guidelines.

2. Scope

This SOP applies to all resins used in purification steps such as affinity, ion-exchange, hydrophobic interaction, and size-exclusion chromatography, across pilot and commercial production units in biosimilar manufacturing.

3. Responsibilities

  • Production: Perform resin regeneration after each cycle and ensure proper storage.
  • QA: Review resin regeneration logs and approve storage status.
  • Engineering: Support resin regeneration by maintaining pumps, skids, and sensor calibration.

4. Accountability

The Head of Downstream Manufacturing is accountable for ensuring all resins are regenerated and stored as per SOP before reuse or archival.

5. Procedure

5.1 Pre-Regeneration Checks

  1. Ensure that the column containing resin has completed its purification or CIP run.
  2. Confirm resin ID, column ID, and product batch in Annexure-1.
  3. Verify the validated regeneration protocol based on resin type.

5.2 Resin Regeneration Steps

  1. Protein A Resin:
    • Wash with 6 CV of 0.1 M NaOH at room temperature
    • Hold for 15 minutes contact time
    • Rinse with WFI until neutral pH
  2. Ion Exchange Resin:
    • Use alternating washes of 1 M NaOH and 1 M NaCl
    • Flush with WFI to remove chemical residues
  3. HIC Resin:
    • Wash with 20% ethanol followed by 0.5 M NaOH
    • Final rinse with WFI

5.3 Storage Conditions

  1. Resins not used for >24 hours must be stored under appropriate conditions:
    • Protein A: 20% ethanol in WFI at 2–8°C
    • IEX: 0.1 M NaCl with 20% ethanol
  2. Fill column with storage buffer until full, avoiding air bubbles.
  3. Seal column ports with sanitary end caps and label with resin ID, storage date, and next due regeneration date.

5.4 Resin Storage Outside Column

  1. Transfer resin to sanitized resin storage bags or vessels.
  2. Ensure continuous suspension and temperature monitoring.
  3. Stir gently every 7 days to maintain resin integrity.

5.5 Documentation and Verification

  1. Record regeneration date, chemicals used, contact times, and observations in Annexure-2.
  2. QA to verify neutralization, pH, and physical integrity before releasing resin for reuse.

6. Abbreviations

  • CIP: Clean-In-Place
  • IEX: Ion Exchange
  • WFI: Water for Injection
  • CV: Column Volume

7. Documents

  1. Resin Regeneration Log – Annexure-1
  2. Storage Condition Record – Annexure-2

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • WHO TRS 999 – GMP for Biologics
  • OEM Resin Guidelines – Cytiva, Bio-Rad, Repligen

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Resin Regeneration Log

Date Resin ID Resin Type Cleaning Agent Contact Time Operator
04/05/2025 RES-PA-104 Protein A 0.1 M NaOH 15 min Ajay Verma

Annexure-2: Storage Condition Record

Resin ID Storage Buffer Storage Temp Storage Date Next Regeneration Due QA Verified
RES-PA-104 20% EtOH in WFI 2–8°C 04/05/2025 04/06/2025 Sunita Reddy

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added guidance for off-column resin storage Operational feedback and QA review
See also  Biosimilars: SOP for Plasmid Amplification and Purification - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Elixir Department: SOP for Cleaning of Mixing Vessels Post-Batch – V 2.0
Next Post: SOPs Don’t Define Time-Stamped Entry Protocols: A GMP Documentation Deficiency

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version